Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli.
about
Shigella Vaccine Development: Finding the Path of Least Resistance.Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study.Engineering and Dissecting the Glycosylation Pathway of a Streptococcal Serine-rich Repeat AdhesinCarbohydrates as T-cell antigens with implications in health and disease.
P2860
Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Purification and characterizat ...... oengineering Escherichia coli.
@en
type
label
Purification and characterizat ...... oengineering Escherichia coli.
@en
prefLabel
Purification and characterizat ...... oengineering Escherichia coli.
@en
P2093
P2860
P356
P1433
P1476
Purification and characterizat ...... oengineering Escherichia coli.
@en
P2093
Andreas Brunner
Corina Ruch
Fabiana S Fernandez
Micha A Haeuptle
Michael Kowarik
Michael Steffen
Michael Wacker
Michael Wetter
Neil Ravenscroft
Paula Carranza
P2860
P356
10.1093/GLYCOB/CWV077
P577
2015-09-09T00:00:00Z